“Now if Gilead is really the invisible hand behi
Post# of 148287
For years, CYDY investors have speculated about Gilead’s involvement in CYDY, ranging from a potential partner in HIV, a candidate to buy CYDY out and even as a entity who could be “holding” leronlimab back via influence on the FDA.
One thing is clear after the PR this morning: Leronlimab is 100% on Gilead’s radar right at this moment. The question is how will Gilead respond?